FDA Expands Use of Dapagliflozin to Broader Range of HF ...Middle East

The SGLT2 inhibitor is now indicated for treatment of heart failure across the full spectrum of left-ventricular ejection fraction ― including HF with mildly reduced and preserved ejection fraction. Medscape Medical News

Hence then, the article about fda expands use of dapagliflozin to broader range of hf was published today ( Tuesday 09/05/2023 - 08:08 PM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Expands Use of Dapagliflozin to Broader Range of HF )

Also on site :

• Country Icon Carrie Underwood’s Latest Career Announcement May Leave Fans Disappointed
• Ferry with 342 aboard sinks in the Philippines (VIDEO)
• Here's What Airlines Owe You if Your Flight Was Canceled or Delayed During This Weekend's Winter Snowstorm